The M.O. Behind Choosing A CDMO: Three Considerations For New Drug Developers

For many who are new to drug development, the greatest challenge is not necessarily discovering a blockbuster molecule, it’s finding a team capable of carrying that molecule through the complexities that lie between the research lab and the patient’s bedside.

That’s especially true as the COVID-19 pandemic continues to disrupt our industry. To get a new drug to market, you must navigate a turbulent global supply chain, a complex regulatory landscape, and an intensely competitive and fast-moving commercial environment, all without losing sight of your reason for starting this journey in the first place: the patient whose life may depend on your product.

To get it right, and to manage it all cost-effectively and on an accelerated timeline, you need the right partner. But how will you know when you’ve found one?

Discover three considerations that build a foundation for partnership.